Network Meta‐Analysis: Comparison of Endoscopic Dysplasia Detection Technologies in Inflammatory Bowel Disease
Alimentary Pharmacology & Therapeutics · 2025
DOI: 10.1111/apt.18500 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2025. Verfasst von Mohammad Shehab und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Mubarak Alkabeer University Hospital, Kuwait University, Kuwait City, Kuwait. Hauptthemen laut MEDLINE: Colonoscopy, Colorectal Neoplasms, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Background
Novel colorectal cancer endoscopic surveillance techniques for inflammatory bowel disease (IBD) have recently been developed.
Aims
Compare the efficacy of currently available techniques for dysplasia detection in colonic IBD.
Methods
We conducted a systematic literature search from inception to March 2024 for randomized controlled trials (RCTs) or prospective cohort studies enrolling adults with IBD and having surveillance colonoscopy for dysplasia screening. Primary outcome was the number of dysplastic lesions (per‐lesion analysis). Secondary outcome was the number of patients with dysplasia (per‐patient analysis). We assessed endpoints using the frequentist NMA random effect model.
Results
We included 25 studies (22 RCTs). 4837 patients met eligibility criteria (850 total dysplastic lesions; 105 with advanced dysplasia). Nine different screening techniques were studied. In per‐lesion analysis, dye‐based chromoendoscopy (DCE) ranked the highest (83%) per SUCRA ranking. DCE was superior to HD‐WLE (OR, 1.78; 95% CI, 1.06–3.00). There were no significant differences between NBI and DCE, HD‐WLE with SR or CEM in head‐to‐head comparisons. In a sub‐analysis confined to ulcerative colitis (UC), DCE ranked highest (98%) with per‐lesion analysis, and was superior to NBI (OR, 1.69; 95% CI, 1.03–2.77).
Conclusions
HD‐WLE‐SR, DCE and CEM demonstrated superiority over other techniques for detection of dysplasia in colonic IBD. DCE was superior for dysplasia detection in colonic IBD. DCE was superior to HD‐WLE in colonic IBD. DCE was the best technique in UC. Further studies to compare HD‐WLE‐SR and NBI with DCE are warranted to ascertain performance equivalency and define the optimal surveillance technique.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Internal Medicine, Mubarak Alkabeer University Hospital, Kuwait University, Kuwait City, Kuwait.
- School of Medicine, Royal College of Surgeons in Ireland - Medical University of Bahrain, Busaiteen, Bahrain.
- Department of Pharmacy Practice, Faculty of Pharmacy, Kuwait University, Jabriya, Kuwait.
- Division of Gastroenterology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- University Hospitals Leuven, TARGID, KU Leven, Leuven, Belgium.
- Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
ORCID-Profile: Mohammad Shehab, Frank Hoentjen
Zitieren
APA
Shehab, M., Al-Hindawi, A., Alrashed, F., Murthy, S., Bisschops, R., Hoentjen, F., Barkun, A., Singh, S., & Bessissow, T. (2025). Network Meta‐Analysis: Comparison of Endoscopic Dysplasia Detection Technologies in Inflammatory Bowel Disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18500
Vancouver
Shehab M, Al-Hindawi A, Alrashed F, Murthy S, Bisschops R, Hoentjen F, et al. Network Meta‐Analysis: Comparison of Endoscopic Dysplasia Detection Technologies in Inflammatory Bowel Disease. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.18500
BibTeX
@article{Shehab2025,
author = {Shehab, Mohammad and Al-Hindawi, Ahmed and Alrashed, Fatema and Murthy, Sanjay and Bisschops, Raf and Hoentjen, Frank and Barkun, Alan and Singh, Siddharth and Bessissow, Talat},
title = {Network Meta‐Analysis: Comparison of Endoscopic Dysplasia Detection Technologies in Inflammatory Bowel Disease},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2025},
doi = {10.1111/apt.18500}
}
EUVIMED